Pasar al contenido principal

FUNCIONES DE LAS ISOFORMAS DE TAU

PID2021-123859OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tridimensional Structural Analysis of Tau Isoforms Generated by Intronic Retention

  • Domene-Serrano, Indalo
  • Cuadros, Raquel
  • Hernandez, Felix
  • Ávila, Jesús
  • Santa-Maria, Ismael
Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Recently, we have discovered a new, human specific, tau isoform termed W-tau that originates by intron 12 retention. Our preliminary data suggests this newly discovered W-tau isoform might prevent aberrant aggregation of other tau isoforms but is significantly downregulated in tauopathies such as Alzheimer's disease., This work has been supported by grants from the Spanish Ministry of Science: PID2020-113204GB-I00 (F.H.) and PID2021-123859OB-100 from MCIN /AEI/10.13039/501100011033 / FEDER, UE (J.A.). The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

  • Ruiz-Gabarre, Daniel
  • Vallés-Saiz, Laura
  • Carnero-Espejo, Almudena
  • Ferrer, Isidro
  • Hernández, Félix
  • Garcia-Escudero, Ramon
  • Ávila, Jesús
  • García-Escudero, Vega
Background: Tau is a microtubule-binding protein encoded by the MAPT gene. Tau is essential for several physiological functions and associated with pathological processes, including Alzheimer's disease (AD). Six tau isoforms are typically described in the central nervous system, but current research paints a more diverse landscape and a more nuanced balance between isoforms. Recent work has described tau isoforms generated by intron 11 and intron 12 retention. This work adds to that evidence, proving the existence of MAPT transcripts retaining intron 3. Our aim is to demonstrate the existence of mature MAPT RNA species that retain intron 3 in human brain samples and to study its correlation with Alzheimer's disease across different regions. Methods: Initial evidence of intron-3-retaining MAPT species come from in silico analysis of RNA-seq databases. We further demonstrate the existence of these mature RNA species in a human neuroepithelioma cell line and human brain samples by quantitative PCR. We also use digital droplet PCR to demonstrate the existence of RNA species that retain either intron 3, intron 12 or both introns. Findings: Intron-3-retaining species are even more prominently present that intron-12-retaining ones. We show the presence of MAPT transcripts that retain both introns 3 and 12. These intron-retaining species are diminished in brain samples of patients with Alzheimer's disease with respect to individuals without dementia. Conversely, relative abundance of intron-3- or intron-12-retaining MAPT species with respect to double-retaining species as well as their percentage of expression with respect to total MAPT are increased in patients with Alzheimer's disease, especially in hippocampal samples. Among these TIR-MAPT species, TIR double truncation allows better classification potential of Alzheimer's disease samples. Moreover, we find a significant increase in intron-3- or intron-12-retaining species and its relative abundance with respect to double-retaining MAPT species in cerebellum in contrast to frontal lateral cortex and hippocampus in individuals with no signs of dementia. Interpretation: Intron retention constitutes a potential mechanism to generate Tau isoforms whose mature RNA expression levels correlate with Alzheimer's pathology showing its potential as a biomarker associated to the disease. Funding: This research was funded by the Spanish Ministry of Science, Innovation and Universities: PGC2018-096177-B-I00 (J.A.); Spanish Ministry of Science and Innovation (MCIN): PID2020-113204GB-I00 (F.H.) and PID2021-123859OB-100 from MCIN/AEI/10.13039/501100011033/FEDER, UE (J.A.). It was also supported by CSIC through an intramural grant (201920E104) (J.A.) and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (J.A.). The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)., This research was funded by the Spanish Ministry of Science, Innovation and Universities: PGC2018-096177-B-I00 (J.A.); Spanish Ministry of Science and Innovation (MCIN): PID2020-113204GB-I00 (F.H.) and PID2021-123859OB-100 from MCIN/AEI/10.13039/501100011033/FEDER, UE (J.A.). It was also supported by CSIC through an intramural grant (201920E104) (J.A.) and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (J.A.). The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of folate receptor α in the partial rejuvenation of dentate gyrus cells: Improvement of cognitive function in 21-month-old aged mice

  • Antón-Fernández, Alejandro
  • Cuadros, Raquel
  • Peinado-Cahuchola, Rocío
  • Hernández, Félix
  • Ávila, Jesús
Neuronal aging may be, in part, related to a change in DNA methylation. Thus, methyl donors, like folate and methionine, may play a role in cognitive changes associated to neuronal aging. To test the role of these metabolites, we performed stereotaxic microinjection of these molecules into the dentate gyrus (DG) of aged mice (an average age of 21 month). Folate, but not S-Adenosyl-Methionine (SAM), enhances cognition in aged mice. In the presence of folate, we observed partial rejuvenation of DG cells, characterized by the expression of juvenile genes or reorganization of extracellular matrix. Here, we have also tried to identify the mechanism independent of DNA methylation, that involve folate effects on cognition. Our analyses indicated that folate binds to folate receptor α (FRα) and, upon folate binding, FRα is transported to cell nucleus, where it is acting as transcription factor for expressing genes like SOX2 or GluN2B. In this work, we report that a FRα binding peptide also replicates the folate effect on cognition, in aged mice. Our data suggest that such effect is not sex-dependent. Thus, we propose the use of this peptide to improve cognition since it lacks of folate-mediated side effects. The use of synthetic FRα binding peptides emerge as a future strategy for the study of brain rejuvenation., PID2020-113204GB-I00/Spanish Ministry of Economy and Competitiveness PGC-2018-09177-B-100/Spanish Ministry of Economy and Competitiveness PID2021-123859OB-100/Agencia Estatal de Investigación 201920E104/Consejo Superior de Investigaciones Científicas
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Could there be an experimental way to link consciousness and quantum computations of brain microtubules?

  • Ávila, Jesús
  • Marco, Jesús
  • Plascencia-Villa, Germán
  • Bajic, Vladan P.
  • Perry, George
Using mathematical analyses, Penrose proposed a relation between consciousness moments and quantum computations occurring in the microtubules (MTs) of the brain. It was suggested that there is a link between brain MTs and consciousness via the entangled stage of delocalized π electrons present in the brain MTs (Hameroff and Penrose, 2014). Then, we will attempt to comment on this hypothesis step by step, looking for a possible future experimental approach that probes the hypothesis., This study was supported by a grant from the Spanish Ministry of Science (PID2021-123859OB-100/AEI/10.13039/501100011033/FEDER, UE) (JA). The Centro de Biología Molecular Severo Ochoa (CBM) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reversion or compensation of mild cognitive impairment to normal cognition: strategies to prevent the development of Alzheimer’s disease continuum

  • Avila Villanueva, Marina
  • Avila, Jesus
Alzheimer’s disease continuum has been described as the progressive stages of the disease over a long period. This progression can be categorized into three main stages: preclinical, mild cognitive impairment (MCI), and dementia. It has been suggested that there is a bidirectional relationship between the preclinical stage and MCI, but not between dementia and the earlier stages. The stage of MCI should be further analyzed, especially in cases where there is a reversion from MCI to a normal cognitive condition. The mechanisms behind this reversion deserve further investigation to differentiate true reversion from compensatory mechanisms. Analyzing reversion in greater detail could help identify potential therapies aimed at preventing or delaying the onset of dementia. As indicated, the primary focus has been on research indicating that MCI can revert to normal cognition. This reversion can occur by addressing risk factors through lifestyle changes, although a novel mechanism involving a transient functional compensation process in response to cognitive impairment should be also taken into account., This work has been supported by a grant from the Spanish Ministry of Science and Innovation [PID2021-123859OB-100] from MCIN/AEI/10.13039/501100011033/FEDER, UE (J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hippocampal rejuvenation by a single intracerebral injection ofone-carbon metabolites in C57BL6 old wild type mice

  • Antón Fernández, Alejandro
  • Peinado Cauchola, Rocío
  • Hernández, Félix
  • Ávila, Jesús
The Izpisua-Belmonte group identified a cocktail of metabolites that promote partial reprogramming in cultured muscle cells. We tested the effect of brain injection of these metabolites in the dentate gyrus of aged wild-type mice. The dentate gyrus is a brain region essential for memory function and is extremely vulnerable to aging. A single injection of the cocktail containing four compounds (putrescine, glycine, methionine and threonine) partially reversed brain aging phenotypes and epigenetic alterations in age-associated genes. Our analysis revealed three levels: chromatin methylation, RNA sequencing, and protein expression. Functional studies complemented the previous ones, showing cognitive improvement. In summary, we report the reversal of various age-associated epigenetic changes, such as the transcription factor Zic4, and several changes related to cellular rejuvenation in the dentate gyrus (DG). These changes include increased expression of the Sox2 protein. Finally, the increases in the survival of newly generated neurons and the levels of the NMDA receptor subunit GluN2B were accompanied by improvements in both short-term and long-term memory performance. Based on these results, we propose the use of these metabolites to explore new strategies for the development of potential treatments for age-related brain diseases., Consejo Superior de Investigaciones Científicas, Grant/Award Number: 201920E104; Dirección General de Universidades e Investigación, Grant/Award Number: S2017/ BMD-3700; Grant/Award Number: PID2020-113204GB-I00 and PID2021- 123859OB-100; the Spanish Ministry of Economy and Competitiveness, Grant/ Award Number: PGC-2018-09177-B-100, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

  • Merino-Serrais, Paula
  • Soria, José Miguel
  • Arrabal, Cristina Aguirre
  • Ortigado-López, Alfonso
  • Esparza, María Ángeles García
  • Muñoz, Alberto
  • Hernández, Félix
  • Ávila, Jesús
  • DeFelipe, Javier
  • León-Espinosa, Gonzalo
Tau has a wide variety of essential functions in the brain, but this protein also plays a determining role in the development of Alzheimer's disease (AD) and other neurodegenerative diseases called tauopathies. This is due to its abnormal aggregation and the subsequent formation of neurofibrillary tangles. Tau hyperphosphorylation appears to be a critical step in its transformation into an aggregated protein. However, the exact process, including the cellular events that trigger it, remains unclear. In this study, we employed immunocytochemistry assays on hippocampal sections from AD cases and from tauopathy cases (Braak stage III) with no evidence of cognitive decline, and the P301S mouse model to investigate the colocalization patterns of Tau phosphorylated (p) at specific residues (S202-T205, S214, and T231) within the proline-rich region. Our results show pyramidal neurons in the hippocampus of P301S mice in which Tau is intensely phosphorylated at residues S202 and T205 (recognized by the AT8 antibody), but with no detectable phosphorylation at S214 or T231. These non-colocalizing neurons displayed intensely labeled aggregated pTau deposits distributed through the soma and dendritic processes. However, most of the hippocampal pyramidal neurons are labeled with pTauS214 or pTauT231 antibodies and typically showed a homogeneous and diffuse pTau distribution (not aggregated). This different labeling likely reflects a Tau conformational step, potentially related to the transition from a diffuse tau phosphorylation phenotype (Type 2) into an NFT-like or Type 1 phenotype. We further observed that dendrites of CA3 pyramidal cells are intensely labeled with pTau214 in the stratum lucidum, but not with AT8 or pTauT231. By contrast, analysis of tissue from AD patients or other human tauopathy cases (Braak stage III) with no evidence of cognitive decline revealed extensive colocalization with both antibody combinations in CA1. The complete or mature tangle development may follow a different mechanism in the P301S mouse model or may require more time to achieve the maturity state found in AD cases. Further studies would be necessary to address this question., This work was supported by a grant from Fundación Universitaria San Pablo CEU-Banco Santander to GLE (FUSP-PPC-19-264E8B2F) and from the following grants to JDF: PID2021-127924NB-I00 funded by MCIN/ AEI/10.13039/501100011033; CSIC Interdisciplinary Thematic Platform - Cajal Blue Brain (PTI-BLUEBRAIN; Spain); and CIBERNED, ISCIII, CB06/05/0066. Work in the laboratory of JA is funded by grants from MCIN/AEI/10.13039/501100011033/FEDER, UE (PID2021- 123859OB-100). Work in the laboratory of FH is funded by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía, Industria y Competitividad, Gobierno de España, PID2020- 113204GB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

  • Vallés-Saiz, Laura
  • Abdelkader-Guillén, Aaron
  • Ávila, Jesús
  • Hernández, Félix
The long-interspersed elements (LINE-1; L1) represent the main active family of retrotransposons in the human organism, comprising approximately 17% of its content. L1 sequence codifies for the two proteins involved in its retrotransposition: ORF1p, an RNA binding protein, and ORF2p, endowed with endonuclease and reverse transcriptase activity. The vast majority of L1 copies are inactive, with only a small percentage retaining their retrotransposition capacity, posing a threat to the organism due to its mutagenic potential. To mitigate such risks, mammals have evolved intricate regulatory mechanisms, including heterochromatin formation and RNA degradation pathways. Age-related diminution in these regulatory pathways may be particularly important within the Central Nervous System (CNS), where cellular regeneration is limited, and genomic integrity is critical for lifelong function. Here, we describe an age-associated upregulation of ORF1p in the mouse brain, indicating a potential role of L1 activity in aging. We further demonstrate the presence of ORF1p across diverse CNS cell types, including neurons, oligodendrocytes and microglia. Notably, we observe a correlation between ORF1p presence and microglial activation, a hallmark of neuroinflammation, during aging. This study advances our understanding of L1 dynamics in the CNS and underscores the significance of L1 in age-related neurological changes., Work in the laboratory of FH is funded by grants from Ministerio de Ciencia, Innovación y Universidades, Gobierno de España (PID2023-149460NB-I00) and Fundación Ramón Areces. Work in the laboratory of JA is funded by grants from Ministerio de Ciencia, Innovación y Universidades, Gobierno de España (PID2021-123859OB-100).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

  • Domene-Serrano, Indalo
  • Cuadros, Raquel
  • García-Escudero, Vega
  • Vallejo-Bedia, Francisco
  • Santa-María, Ismael
  • Vallés-Saiz, Laura
  • Hernandez, Félix
  • Avila, Jesús
Tauopathies comprise a range of neurodegenerative conditions characterized by the aberrant accumulation of tau protein clumps in the brain. These aggregates are formed by different tau splicing isoforms. Here, we analyzed the role of a specific intron-derived peptide called the W-Tau peptide on the polymerization–depolymerization of tau filaments. This peptide originates from a new isoform of the tau protein, named W-Tau, which is formed due to the retention of intron 12. AlphaFold3 (AF3)-based in silico investigations suggested that the W-Tau peptide interacts with tau monomers. Our in vitro experiments confirmed these predictions and showed that the W-Tau peptide inhibited tau aggregation. In addition, the W-Tau peptide disrupted preexisting paired helical filaments (PHFs) isolated from postmortem brain samples of patients with Alzheimer’s disease, thereby supporting its potential therapeutic value. The effectiveness of the W-Tau peptide was demonstrated by the decrease in tau aggregation observed after cotransfection of the W-Tau peptide and PHF seeds, as demonstrated by analysis involving a fluorescence resonance energy transfer (FRET) cell biosensor. The W-Tau peptide breaks PHFs by selectively attaching to their ends, causing the structures to unwind and convert into circle-like formations. Considering the potential neuroprotective effects against tauopathies, the W-Tau isoform and its peptide are interesting candidates for future therapeutic interventions., This work has been supported by grants from the Spanish Ministry of Science: PID2020-113204GB-I00 (F.H.) and PID2021-123859OB-100 from MCIN/AEI/10.13039/501100011033/FEDER, UE (J.A.). The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIN, award CEX2021-001154-S).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure and function of Full-length Tau

  • Vallés-Saiz, Laura
  • Domene-Serrano, Indalo
  • Picher, Angel J.
  • Pérez, Mar
  • García-Escudero, Vega
  • Hernández, Félix
  • Avila, Jesús
Tau protein, encoded by the MAPT gene, is a microtubule-associated protein involved in the regulation of microtubule stability in neurons, contributing to cell shape maintenance and intracellular transport, among other functions. Tau is not found as a unique isoform; instead, different Tau isoforms of varying sizes are present in the brain, but a Full-length Tau isoform (Full Tau) containing all 16 exons has never been previously identified. This study has explored the structure and function of the Full Tau isoform, which includes all exons of the MAPT gene. To achieve this, we expressed the Full Tau isoform in bacteria, alongside the Tau 4R2N isoform as a control, and tested its microtubule-binding capacity, self-aggregation propensity, and effects on cultured cells regarding cell proliferation and cell death. Our results indicated several differences between the Full Tau and Tau 4R2N isoforms, suggesting distinct roles in cellular dynamics. To explain these differences, we suggest the role of exon 8, which is present in the Full Tau isoform but absent in Tau 4R2N., This work was supported by grants from the Spanish Ministry of Science (MICIU): PID2023-149460NB-I00 (Dr. Felix Hernández), PID2021-123859OB-I00 (Dr. Jesús Avila), and PID2024-1554470OB-I00 (Dr. Jesús Avila), from MICIU/AEI/10.13039/501100011033/ FEDER, UE (Financial) Laura Vallés-Saiz received a salary from the PID2021- 123859OB-I00 project from MICIU. 4basebio S.L.U. Supported A.J.P. in the form of salary and research materials for the study. The Centro de Biología Molecular Severo Ochoa (CBMSO) is a Severo Ochoa Center of Excellence (MICIU, award CEX2021-001154-S)